|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 520.60 USD | -0.99% |
|
-1.41% | +6.93% |
| Market Cap | 22.32B 19.4B 18.06B 16.58B 31.31B 2,131B 31.8B 213B 83.55B 1,061B 83.82B 81.98B 3,557B | P/E 2026 * |
19.5x | P/E 2027 * | 16.7x |
|---|---|---|---|---|---|
| Enterprise Value | 19.67B 17.1B 15.92B 14.62B 27.6B 1,878B 28.03B 188B 73.64B 935B 73.89B 72.26B 3,135B | EV / Sales 2026 * |
6.08x | EV / Sales 2027 * | 5.01x |
| Free-Float |
53.7% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: United Therapeutics Corporation
| 1 day | -1.00% | ||
| 1 week | -1.41% | ||
| Current month | -3.84% | ||
| 1 month | -4.78% | ||
| 3 months | -8.66% | ||
| 6 months | +9.69% | ||
| Current year | +6.93% |
| 1 week | 514.34 |  | 535.22 |
| 1 month | 514.34 | | 563.7 |
| Current year | 455.63 | | 609.35 |
| 1 year | 283.01 | | 609.35 |
| 3 years | 208.62 | | 609.35 |
| 5 years | 158.38 | | 609.35 |
| 10 years | 74.31 | | 609.35 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 71 | 26/06/1996 | |
| President | 54 | 26/06/2016 | |
James Edgemond
DFI | Director of Finance/CFO | 58 | 13/03/2015 |
| Director | Title | Age | Since |
|---|---|---|---|
Raymond Kurzweil
BRD | Director/Board Member | 78 | 01/01/2002 |
| Chairman | 71 | 26/06/1996 | |
Louis Sullivan
BRD | Director/Board Member | 92 | 01/01/2002 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 29/07/26 | Fiscal year | Chief Executive Officer | 28,500 | 0.0671% | ||
| 28/07/26 | Fiscal year | Chief Executive Officer | 28,500 | 0.0671% | ||
| 27/07/26 | Fiscal year | Chief Executive Officer | 28,500 | 0.0671% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.99% | -1.41% | +89.67% | +114.66% | 22.32B | |
| -0.92% | -4.44% | +54.44% | +151.45% | 1,030B | |
| +0.77% | -2.14% | +56.46% | +53.86% | 617B | |
| -2.34% | -3.10% | +32.95% | +68.01% | 455B | |
| +0.06% | -0.42% | +37.53% | +30.67% | 350B | |
| -0.14% | -0.24% | +34.41% | +39.01% | 299B | |
| -0.69% | -0.30% | +11.55% | +12.93% | 265B | |
| -7.37% | -4.40% | -2.54% | -43.87% | 225B | |
| -0.52% | +2.30% | +30.36% | +64.30% | 209B | |
| -0.71% | +0.71% | +15.97% | +71.03% | 163B | |
| Average | -1.22% | +4.12% | +36.08% | +56.20% | 363.5B | |
| Weighted average by Cap. | -0.95% | +4.83% | +39.26% | +72.52% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.24B 2.81B 2.62B 2.4B 4.54B 309B 4.61B 30.86B 12.11B 154B 12.15B 11.89B 516B | 3.68B 3.2B 2.98B 2.73B 5.16B 351B 5.24B 35.1B 13.78B 175B 13.82B 13.52B 586B |
| Net income | 1.25B 1.08B 1.01B 925M 1.75B 119B 1.77B 11.88B 4.66B 59.21B 4.68B 4.58B 199B | 1.47B 1.28B 1.19B 1.1B 2.07B 141B 2.1B 14.06B 5.52B 70.07B 5.54B 5.42B 235B |
| Net Debt | -2.65B -2.3B -2.14B -1.97B -3.71B -253B -3.77B -25.23B -9.9B -126B -9.94B -9.72B -422B | -3.87B -3.36B -3.13B -2.87B -5.43B -369B -5.51B -36.9B -14.48B -184B -14.53B -14.21B -617B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 31/07/26 | $520.41 | -1.03% | 178,509 |
| 30/07/26 | $525.82 | +0.21% | 472,490 |
| 29/07/26 | $524.70 | +0.20% | 560,581 |
| 28/07/26 | $523.63 | -0.82% | 446,331 |
| 27/07/26 | $527.94 | -0.10% | 431,349 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- UTHR Stock
Select your edition
All financial news and data tailored to specific country editions
